ALX Oncology  Inc. logo

ALX Oncology Inc.

ALXO | NASDAQ
Chart Builder DCF Calculator
$1.62
-$0.04 (-2.41%)
Sep 22, 2026, 12:03 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-101.7M -134.85M -160.81M -123.48M -83.46M -45.74M
Depreciation & Amortization
706K 872K 836K 342K 51K 202K
Stock-Based Compensation
12.58M 27.09M 26.27M 23.84M 13.91M 5.44M
Other Working Capital
-85K -8.41M 7.84M 5.34M -7.32M 3.46M
Other Non-Cash Items
3.93M -2.6M -4.97M 228K 5.42M 1.57M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
336K -12.43M 8.3M 9.85M -4.03M 247K
Operating Cash Flow
-84.14M -121.91M -130.36M -89.22M -68.1M -38.29M
Capital Expenditures
-212K -447K -1.27M -1.43M -4.92M -31K
Cash Acquisitions
n/a n/a n/a 233.99K n/a n/a
Purchase of Investments
-51.59M -107.41M -246.63M -376.79M n/a n/a
Sales Maturities Of Investments
134.39M 194.11M 292.56M 142.8M n/a n/a
Other Investing Acitivies
n/a n/a n/a -233.99K -4.26M 641K
Investing Cash Flow
82.59M 86.26M 44.66M -235.42M -4.92M 610K
Debt Repayment
-1.36M -827K -388K 9.61M -281K n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 792K -655K n/a -10.06M
Financial Cash Flow
362K 30.82M 59.29M 9.86M 2.47M 462.88M
Net Cash Flow
-1.19M -4.84M -26.42M -314.78M -70.55M 425.2M
Free Cash Flow
-84.35M -122.36M -131.64M -90.65M -73.02M -38.32M
Adj. Free Cash Flow
-96.93M -149.45M -157.91M -114.49M -86.94M -43.76M
Maintenance CapEx
-212K -447K -1.27M -1.43M -4.92M -31K
Growth CapEx
n/a n/a n/a n/a n/a n/a
Owner Earnings
-84.35M -122.36M -131.64M -90.65M -73.02M -38.32M

© 2026 bestshares.com. All rights reserved.